BR9916141A - Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos - Google Patents

Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos

Info

Publication number
BR9916141A
BR9916141A BR9916141-9A BR9916141A BR9916141A BR 9916141 A BR9916141 A BR 9916141A BR 9916141 A BR9916141 A BR 9916141A BR 9916141 A BR9916141 A BR 9916141A
Authority
BR
Brazil
Prior art keywords
canis
homologous
protein
ehrlichia canis
genes
Prior art date
Application number
BR9916141-9A
Other languages
English (en)
Portuguese (pt)
Inventor
David H Walker
Xue-Jie Yu
Jere W Mcbride
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/201,458 external-priority patent/US6458942B1/en
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of BR9916141A publication Critical patent/BR9916141A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9916141-9A 1998-11-30 1999-11-24 Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos BR9916141A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/201,458 US6458942B1 (en) 1998-11-30 1998-11-30 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof
US09/261,358 US6403780B1 (en) 1998-11-30 1999-03-03 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
PCT/US1999/028075 WO2000032745A2 (en) 1998-11-30 1999-11-24 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof

Publications (1)

Publication Number Publication Date
BR9916141A true BR9916141A (pt) 2001-12-04

Family

ID=26896771

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916141-9A BR9916141A (pt) 1998-11-30 1999-11-24 Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos

Country Status (11)

Country Link
EP (1) EP1470223A4 (https=)
JP (1) JP2003527073A (https=)
CN (1) CN1535314A (https=)
AU (1) AU762315B2 (https=)
BR (1) BR9916141A (https=)
CA (1) CA2352466A1 (https=)
IL (1) IL143415A0 (https=)
NZ (1) NZ511922A (https=)
RU (1) RU2237716C2 (https=)
TW (1) TWI221481B (https=)
WO (1) WO2000032745A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888491B2 (en) 1998-09-18 2011-02-15 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6544517B1 (en) 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en) 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US7335754B2 (en) 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
US20020064531A1 (en) 2000-05-01 2002-05-30 Walker David H. Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family
US6432649B1 (en) * 2000-08-25 2002-08-13 The Ohio State University Research Foundation Methods for detecting Ehrlichia canis and Ehrlichia chaffeensis in vertebrate and invertebrate hosts
WO2008137881A2 (en) 2007-05-04 2008-11-13 The Ohio State University Research Foundation Ehrlichia ewingii proteins, nucleic acids, and methods of their use
WO2012135701A2 (en) 2011-03-31 2012-10-04 The Ohio State University Compositions and methods for the detection of anaplasma platys
CN105051541B (zh) 2012-10-11 2017-07-04 爱贝斯股份有限公司 用于检测埃里希体属抗体的肽、装置和方法
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
WO2025118050A1 (pt) * 2023-12-04 2025-06-12 Laboratório Bio-Vet Ltda Antígeno vacinal quimérico com ação tríplice contra erliquiose, anaplasmose e babesiose canina, vetor de expressão, célula recombinante, composição vacinal, kit de diagnóstico, método de tratamento e uso de proteína quimérica

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025338A (en) * 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
CA2304256C (en) 1997-09-19 2014-12-09 Yasuko Rikihisa Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis

Also Published As

Publication number Publication date
JP2003527073A (ja) 2003-09-16
AU1923400A (en) 2000-06-19
IL143415A0 (en) 2002-04-21
CN1535314A (zh) 2004-10-06
EP1470223A2 (en) 2004-10-27
CA2352466A1 (en) 2000-06-08
TWI221481B (en) 2004-10-01
WO2000032745A3 (en) 2004-05-21
AU762315B2 (en) 2003-06-19
RU2237716C2 (ru) 2004-10-10
NZ511922A (en) 2003-10-31
WO2000032745A2 (en) 2000-06-08
EP1470223A4 (en) 2005-04-06

Similar Documents

Publication Publication Date Title
BR0113818A (pt) Genes de proteìna imunodominante de vinte e oito quilodáltons, homóloga à ehrlichia canis e uso dos mesmos
BR9916141A (pt) Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos
Krohne et al. Nuclear lamin LI of Xenopus laevis: cDNA cloning, amino acid sequence and binding specificity of a member of the lamin B subfamily.
RU2733492C2 (ru) Новые гибридные ActRIIB белки-ловушки лигандов для лечения заболеваний, связанных с мышечной атрофией
Sellos et al. Molecular cloning of hemocyanin cDNA from Penaeus vannamei (Crustacea, Decapoda): structure, evolution and physiological aspects
EP1767546A4 (en) AN ANGIOGENESIS INHIBITING CHIMERIC PROTEIN AND ITS USE
ATE442373T1 (de) Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
ATE366319T1 (de) Adeno-assoziierte virus-vermittelte übertragung von angiogenesefaktoren
ATE315660T1 (de) Intergene regionen als insertionsstellen im genom von modifiziertem vaccinia virus ankara (mva)
DK1185660T3 (da) Svinecircovirus-vaccine i rekombinant poxvirus
ATE435923T1 (de) Neue polynukleotide und polypeptide des erythropoietingens
Blanton et al. Characterization of a native and recombinant Schistosoma haematobium serine protease inhibitor gene product
ATE404217T1 (de) Therapie mit lipoproteinlipase (lpl) variant
Goraczniak et al. Structural and functional characterization of a second subfamily member of the calcium-modulated bovine rod outer segment membrane guanylate cyclase, ROS-GC2
Savin et al. Characterization, cloning and host-protective activity of a 30-kilodalton glycoprotein secreted by the parasitic stages of Trichostrongylus colubriformis
ES2822924T3 (es) Composición para prevenir o tratar una enfermedad arterial periférica utilizando el factor de crecimiento de hepatocitos y el factor 1a derivado de células del estroma
Cao et al. Characterization, cloning and expression of the 67-kDA annexin from chicken growth plate cartilage matrix vesicles
Rogers et al. Genomic characterization of the human type I cuticular hair keratin hHa2 and identification of an adjacent novel type I hair keratin gene hHa5
Sun et al. Molecular cloning and characterization of Fc-TSP from the Chinese shrimp Fennerpenaeus chinensis
PE20010066A1 (es) Polipeptido de proteina c activada
ES2329584T3 (es) Proteinas de garrapatas de union a quimiocinas cc.
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
Dewi et al. Cloning, sequence analysis, and expression of CIDR1α-pfEMP1 from Indonesian plasmodium falciparum isolate
BR9508645B1 (pt) seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma.
BR9814433A (pt) "beta-lipotropina e usos da mesma"

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII E IX), 11, 13 E 24 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.